Crossmark

Computational identification of novel therapeutic candidates for Streptococcus pyogenes and influenza A coinfections through transcriptomic-based drug repositioning

Crossref DOI link: https://doi.org/10.1186/s12866-026-05063-y

Published Online: 2026-04-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Strey, Kevin

Sueto, Salem

Fuellen, Georg

Kreikemeyer, Bernd

Patenge, Nadja

Barrantes, Israel
Funding

Funding for this research was provided by:

Universitätsmedizin Rostock
License Information

Text and Data Mining valid from 2026-04-23

Version of Record valid from 2026-04-24
More Information

Article History

Received: 12 August 2025

Accepted: 10 April 2026

First Online: 23 April 2026

Declarations

:

: Not applicable. This study used only commercially available cell lines (Detroit 562) and did not involve human participants, human data, or human tissue. All experiments were conducted using cell culture methodologies in vitro.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below